Latent Tuberculosis Infection Resources
Targeted Testing & Treatment Recommendations
CDC Guidance
- Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
- Update on Recommendations for Use of Once-weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium Tuberculosis Infection
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
Additional Resources
- CDC Medscape Commentary: Latent TB Infection Updated Treatment Recommendations
- USPSTF Latent Tuberculosis Infection: Screening Recommendation
- The Journal of the American Medical Association (JAMA)
- Bright Futures Recommendations for Pediatric Preventive Health Care
- Latent TB Infection in the United States – Published Estimates
CDC Resources for USPSTF Recommendations
- American Journal of Nursing: Tuberculosis: A New Screening Recommendation and an Expanded Approach to Elimination in the United States
- Video: 5 Things to Know About TB
- Kelcie’s Story of LTBI Testing and Treatment
- CDC Messages and Resources [PDF – 592 KB]
- USPSTF LTBI Recommendation: Statement from Dr. Phillip LoBue, Director, CDC’s Division of Tuberculosis Elimination
- Sample Communication Templates for Partners
- USPSTF Recommendation Statement: Screening for Latent Tuberculosis Infection (LTBI) in Adults (slide set)
- Huffington Post: The End Game – Eliminating Tuberculosis In America by NCHHSTP Director Dr. Jonathan Mermin
- CDC Medscape Commentary: New Recommendations to Support Latent Tuberculosis Testing
- The Lancet Infectious Diseases: Latent TB infection: the final frontier of TB elimination in the USA
.png)
No hay comentarios:
Publicar un comentario